Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAXIMILIAN E GARCES

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1588650436
CMS profile
253515
Location
YORBA LINDA, CA

General Payments · PY2018–2024

$1,697.66

  • Reported across 98 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$263.06

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $263.06 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $75.80 4
Lilly USA, LLC $71.39 4
Boehringer Ingelheim Pharmaceuticals, Inc. $46.73 3
Amgen Inc. $28.95 1
PFIZER INC. $20.78 1
GlaxoSmithKline, LLC. $19.41 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $325.12 19
PY2019 $495.42 33
PY2020 $97.31 5
PY2022 $191.25 10
PY2023 $325.50 17
PY2024 $263.06 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $28.95 01/17/2024 Food and Beverage Undisputed 01/23/2026 1117257229 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.07 06/06/2024 Food and Beverage Undisputed 01/23/2026 1118070268 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.44 09/05/2024 Food and Beverage Undisputed 01/23/2026 1118070270 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.22 11/21/2024 Food and Beverage Undisputed 01/23/2026 1118070272 CMS
GlaxoSmithKline, LLC. $19.41 04/04/2024 Food and Beverage Undisputed 01/23/2026 1116045269 CMS
Lilly USA, LLC $13.82 01/31/2024 Food and Beverage Undisputed 01/23/2026 1135185857 CMS
Lilly USA, LLC $20.57 03/27/2024 Food and Beverage Undisputed 01/23/2026 1135185859 CMS
Lilly USA, LLC $23.36 05/30/2024 Food and Beverage Undisputed 01/23/2026 1135180349 CMS
Lilly USA, LLC $13.64 08/01/2024 Food and Beverage Undisputed 01/23/2026 1135196694 CMS
Novo Nordisk Inc $17.54 02/15/2024 Food and Beverage Undisputed 01/23/2026 1096602565 CMS
Novo Nordisk Inc $18.75 04/25/2024 Food and Beverage Undisputed 01/23/2026 1097217434 CMS
Novo Nordisk Inc $22.87 07/18/2024 Food and Beverage Undisputed 01/23/2026 1097500649 CMS
Novo Nordisk Inc $16.64 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097150006 CMS
PFIZER INC. $20.78 09/26/2024 Food and Beverage Undisputed 01/23/2026 1132038120 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.